AbbVie Inc.
BG ˙ BUL ˙ US00287Y1091
SecurityBG:4AB / AbbVie Inc.
InstitutionJacobs & Co/ca
Latest Disclosed Ownership61,196 shares
Latest Disclosed Value $ 13,309
Jacobs & Co/ca reports 4.43% increase in ownership of 4AB / AbbVie Inc.

On April 7, 2026 - Jacobs & Co/ca filed a 13F-HR form disclosing ownership of 61,196 shares of AbbVie Inc. (BG:4AB) valued at $13,309 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 5, 2026 disclosing 58,602 shares of AbbVie Inc.. This represents a change in shares of 4.43% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-07 2026-03-31 13F AbbVie COM 00287Y109 61,196 2,594 4.43 13 0.00 1.3136
2026-01-05 2025-12-31 13F AbbVieInc COM 00287Y109 58,602 -1,498 -2.49 13 0.00 1.2634
2025-10-01 2025-09-30 13F AbbVie COM 00287Y109 60,100 -1,539 -2.50 14 18.18 1.3312
2025-07-02 2025-06-30 13F AbbVie COM 00287Y109 61,639 1,211 2.00 11 -8.33 1.1352
2025-04-03 2025-03-31 13F AbbVieInc COM 00287Y109 60,428 -186 -0.31 13 20.00 1.3495
2025-01-10 2024-12-31 13F AbbVieInc COM 00287Y109 60,614 -312 -0.51 11 -16.67 1.0957
2024-10-01 2024-09-30 13F AbbVie COM 00287Y109 60,926 -919 -1.49 12 20.00 1.2030
2024-07-12 2024-06-30 13F AbbVie COM 00287Y109 61,845 649 1.06 11 -9.09 1.1117
2024-04-12 2024-03-31 13F AbbVieInc COM 00287Y109 61,196 -1,737 -2.76 11 22.22 1.1796
2024-01-18 2023-12-31 13F AbbVieInc COM 00287Y109 62,933 -292 -0.46 10 0.00 1.1061
2023-10-13 2023-09-30 13F AbbVieInc COM 00287Y109 63,225 -963 -1.50 9 12.50 1.1744
2023-07-11 2023-06-30 13F AbbVie COM 00287Y109 64,188 -7,772 -10.80 9 -27.27 1.0283
2023-04-17 2023-03-31 13F AbbVie COM 00287Y109 71,960 -2,417 -3.25 11 -8.33 1.4159
2023-01-13 2022-12-31 13F AbbVie COM 00287Y109 74,377 956 1.30 12 -99.88 1.5645
2022-10-11 2022-09-30 13F AbbVie COM 00287Y109 73,421 -880 -1.18 9,853 -13.41 1.4164
2022-07-19 2022-06-30 13F AbbVie COM 00287Y109 74,301 -1,761 -2.32 11,379 -7.71 1.5239
2022-04-14 2022-03-31 13F AbbVie COM 00287Y109 76,062 -1,527 -1.97 12,330 17.37 1.3652
2022-01-21 2021-12-31 13F AbbVie COM 00287Y109 77,589 2,587 3.45 10,505 29.85 1.0892
2021-10-13 2021-09-30 13F AbbVie COM 00287Y109 75,002 4,513 6.40 8,090 1.90 0.9305
2021-07-15 2021-06-30 13F AbbVie COM 00287Y109 70,489 -1,980 -2.73 7,939 1.24 0.9170
2021-04-05 2021-03-31 13F AbbVie COM 00287Y109 72,469 -560 -0.77 7,842 0.22 0.9584
2021-01-12 2020-12-31 13F AbbVie COM 00287Y109 73,029 958 1.33 7,825 23.97 1.0164
2020-12-03 2020-09-30 13F AbbVie COM 00287Y109 72,071 7,209 11.11 6,312 -0.88 0.9158
2020-07-09 2020-06-30 13F AbbVie COM 00287Y109 64,862 4,000 6.57 6,368 37.33 1.0365
2020-04-13 2020-03-31 13F Abbvie COM 00287Y109 60,862 4,020 7.07 4,637 -7.85 0.8950
2020-01-29 2019-12-31 13F Abbvie COM 00287Y109 56,842 2,137 3.91 5,032 21.49 0.7644
2019-11-04 2019-09-30 13F Abbvie COM 00287Y109 54,705 -2,854 -4.96 4,142 -1.03 0.6717
2019-08-01 2019-06-30 13F Abbvie COM 00287Y109 57,559 -2,516 -4.19 4,185 -13.55 0.6755
2019-04-29 2019-03-31 13F Abbvie COM 00287Y109 60,075 -2,622 -4.18 4,841 -16.25 0.8245
2019-02-07 2018-12-31 13F Abbvie COM 00287Y109 62,697 -9,056 -12.62 5,780 -14.82 1.1392
2018-10-23 2018-09-30 13F Abbvie COM 00287Y109 71,753 2,188 3.15 6,786 5.29 1.1475
2018-07-19 2018-06-30 13F Abbvie COM 00287Y109 69,565 -995 -1.41 6,445 -3.49 1.1671
2018-04-27 2018-03-31 13F Abbvie COM 00287Y109 70,560 -2,225 -3.06 6,678 -5.13 1.2334
2018-02-09 2017-12-31 13F Abbvie COM 00287Y109 72,785 -2,990 -3.95 7,039 4.54 1.2721
2017-11-14 2017-09-30 13F Abbvie COM 00287Y109 75,775 -1,744 -2.25 6,733 19.80 1.2658
2017-07-13 2017-06-30 13F Abbvie COM 00287Y109 77,519 -362 -0.46 5,620 10.76 1.1066
2017-04-12 2017-03-31 13F Abbvie COM 00287Y109 77,881 -542 -0.69 5,074 3.34 1.0427
2017-01-18 2016-12-31 13F Abbvie COM 00287Y109 78,423 155 0.20 4,910 -0.53 1.0650
2016-10-11 2016-09-30 13F Abbvie COM 00287Y109 78,268 745 0.96 4,936 2.85 1.1006
2016-07-08 2016-06-30 13F Abbvie COM 00287Y109 77,523 3,365 4.54 4,799 13.32 1.1274
2016-04-14 2016-03-31 13F Abbvie COM 00287Y109 74,158 1,028 1.41 4,235 5.61 1.0192
2016-01-14 2015-12-31 13F Abbvie COM 00287Y109 73,130 2,440 3.45 4,010 4.26 1.0387
2015-10-15 2015-09-30 13F Abbvie COM 00287Y109 70,690 1,914 2.78 3,846 -16.77 1.0214
2015-07-02 2015-06-30 13F Abbvie COM 00287Y109 68,776 -64 -0.09 4,621 14.67 1.1566
2015-04-07 2015-03-31 13F Abbvie COM 00287Y109 68,840 12,300 21.75 4,030 8.95 1.0207
2015-03-10 2014-12-31 13F Abbvie COM 00287Y109 56,540 3,315 6.23 3,699 20.33 0.9738
2014-10-07 2014-09-30 13F Abbvie COM 00287Y109 53,225 237 0.45 3,074 34.18 0.8694
2014-07-16 2014-06-30 13F/A-1 Abbvie COM 00287Y109 52,988 -1,316 -2.42 2,291 -17.91 0.6640
2014-07-15 2014-06-30 13F Abbvie COM 00287Y109 52,988 2,291
2014-04-22 2014-03-31 13F Abbvie COM 00287Y109 54,304 405 0.75 2,791 -1.93 0.8657
2014-01-27 2013-12-31 13F Abbvie COM 00287Y109 53,899 -175 -0.32 2,846 17.70 0.9108
2013-10-09 2013-09-30 13F Abbvie COM 00287Y109 54,074 -1,575 -2.83 2,418 5.13 0.8408
2013-07-19 2013-06-30 13F Abbvie COM 00287Y109 55,649 55,649 2,300 0.8335
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.